Long-Term Clinical and Multimodal Imaging Findings in Patients with Disseminated Mycobacterium Chimaera Infection

February 12, 2026
Share on

AUTHORS

Sandrine Anne Zweifel, Maximilian Robert Justus Wiest, Mario Damiano Toro, Pascal Hasler, Peter Maloca, Barbara Hasse, Nina Khanna, Robert Rejdak

J Clin Med. 2021 Sep 16;10(18):4178. doi: 10.3390/jcm10184178.

ABSTRACT

BACKGROUND: To analyze long-term ophthalmic clinical and multimodal imaging findings of disseminated Mycobacterium (M.) chimaera infection after cardiothoracic surgery among the Swiss Cohort.

METHODS: Systemic and multimodal ophthalmic imaging and clinical findings including rate of recurrence were reviewed and correlated to a previously proposed classification system of choroidal lesions and classification of ocular disease.

MAIN OUTCOMES MEASURES: long-term clinical and multimodal ocular imaging findings of M. chimaera.

RESULTS: Twelve patients suffering from systemic infection from M. chimaera were included. Mean age at the first ophthalmic examination was 59 years (range from 48 to 66 years). Mean duration of the follow-up was 22.63 ± 17.8 months. All patients presented with bilateral chorioretinal lesions at baseline; 5 patients had additional signs, including optic disc swelling (2), choroidal neovascularization (1), retinal neovascularization (1) and cilioretinal vascular occlusion (1). Four recurrence events after discontinuation or adjustment of the antibiotic treatment were observed. Progressive choroiditis was seen in 5 patients under treatment, 4 of them deceased.

CONCLUSIONS: Expertise from ophthalmologists is not only relevant but also critical for the assessment of the adverse drug effect of antimycobacterial treatment along with monitoring therapeutic response and identifying recurrences.

PMID:34575289 | PMC:PMC8464780 | DOI:10.3390/jcm10184178

View in PubMed